Comparison of the efficacy and risk of discontinuation between non-TNF-targeted treatment and a second TNF inhibitor in patients with rheumatoid arthritis after first TNF inhibitor failure

OBJECTIVES: Despite improved care for rheumatoid arthritis (RA) patients, many still experience treatment failure with biologic disease-modifying antirheumatic drugs (bDMARDs) or targeted synthetic DMARDs [tsDMARDs; typically Janus kinase inhibitors (JAKi)], and eventually switch to other agents. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Dong-Jin, Choi, Sung-Eun, Kang, Ji-Hyoun, Shin, Kichul, Sung, Yoon-Kyoung, Lee, Shin-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021479/
https://www.ncbi.nlm.nih.gov/pubmed/35464808
http://dx.doi.org/10.1177/1759720X221091450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021479/
https://www.ncbi.nlm.nih.gov/pubmed/35464808
http://dx.doi.org/10.1177/1759720X221091450

Ejemplares similares